Imagine you are a business owner in the gambling or cigarette industries who has just invested millions in game-changing innovations. But then the government says your industry is no longer eligible for R&D tax incentives.
When all of a sudden, your innovation funding disappears, leaving you to fret over the future of your projects. As of July 2025, this will be the case for many Australian businesses due to the government’s decision to exclude gambling and tobacco from the R&D Tax Incentive program. In this blog post, we will go through the various implications of this, why it is occurring, and how it will impact innovation in multiple sectors.
Why the Change? Aligning Public Funding with Societal Values
Not only are the gambling and tobacco industries excluded from the benefits of the R&D Tax Incentive scheme, but the Australian government has also made a statement about it. Businesses in various industries have been encouraged to participate in research and development through the R&D tax incentives program, which has been a pillar of innovation for decades. The government, however, has just drawn a line in the sand, stating categorically that sectors associated with social damage should not get public funding.
The statement, which is a part of the Mid-Year Economic and Fiscal Outlook (MYEFO) for 2024–25, mentions that gambling and tobacco can worsen health risks and addiction. The government’s goal in excluding certain industries is to refocus public funds on research and development projects that have a stronger connection to public health and the welfare of society as a whole.
However, there are others who disagree with this judgment. Some critics argue that it might pave the way for similar exclusions in other industries, such as the fast food, alcohol, or fossil fuel industries.
The Immediate Impact: What Changes for Gambling and Tobacco Companies?
There will be a complete elimination of tax incentives for research and development expenditures by the gambling and tobacco industries in July 2025. Several immediate effects will follow from this change:
- Reduced Financial Support for Innovation: The tobacco and gambling industries will see increased innovation expenses without the R&D Tax Incentive. One tobacco company, for example, will have to pay for these expenses out of pocket. It received $39.5 million in tax offsets for research and development in 2021 and 2022. If businesses see no return on investment (ROI) from investing in new products or technologies, they may drastically cut back on R&D spending.
- Shift in R&D Focus: Projects focused on harm reduction, such as technology to minimise addiction or generate safer products and services, will still be eligible for tax incentives, but broader R&D activities will not. Therefore, businesses may shift their R&D efforts towards harm reduction strategies instead of focusing on broader innovations.
Potential Job Losses and Relocation
The exclusion could force research and development jobs to go overseas in search of countries with more favourable tax conditions. This could lead to a decline in the nation’s role as an innovator in those industries, and skilled workers would leave, posing a significant threat to the industry’s stability and growth.
The Bigger Picture: Global Competitiveness at Risk
The exclusion from the R&D Tax Incentive doesn’t just affect Australian companies—it could also impact their ability to compete on a global scale. Here’s how:
- Increased Cost of Innovation: Gambling and tobacco industries in Australia would find it difficult to compete with their international competitors if tax incentives are eliminated. In today’s dynamic global market, this situation will put them at a disadvantage.
- Relocation of R&D Activities: Australia risks missing out on potential innovations and economic benefits if businesses outsource their R&D operations to other countries. The excluded industries would take a hit, and related sectors like retail and hotels would feel the ripple effect.
- Regulatory Challenges: Due to tighter government regulations on gambling and tobacco, businesses will be required to invest more in compliance methods. This may take money away from innovation, which would hurt their ability to compete on a global scale.
A Contradiction in Policy? Innovation vs. Public Health
Promoting innovation while safeguarding public health is a highly controversial part of the government’s decision. The R&D Tax Incentive has played a significant role in driving innovation in Australia, assisting businesses in developing new products and technologies that contribute to economic growth. However, the government’s argument that public funding should not support companies associated with addiction and health hazards creates a complex and challenging policy landscape.
But here’s the catch: Some parts of the R&D activities in these industries are focused on reducing harm. For example, tobacco companies have been looking into alternatives like electronic cigarettes, while gambling companies have been investing in technologies to encourage safe and responsible gambling. By excluding these industries completely, the government risks stifling innovation that could benefit public health.
What’s Next? The Road Ahead for Gambling and Tobacco Companies
The question then becomes, what does this mean for the gambling and tobacco industries? Some possible next steps are as follows:
- Pivot to Harm Reduction: Companies should shift their R&D efforts towards harm reduction methods, which can still be eligible for R&D tax incentives. This may involve investing in technology that reduces addiction, developing safer products, or enhancing consumer protections.
- Explore Other Sources of Funding: Without the R&D Tax Incentive, businesses could have to seek out alternative funding sources, such as forming collaborations with research institutes or seeking private investment.
- Advocate for Policy Change: Government officials are being urged by industry leaders to rethink the decision and consult with stakeholders more thoroughly. Together, they can tackle public health issues while still fostering innovation.
Final Thoughts: A Balancing Act
It is a courageous step toward bringing public funds in line with social principles, and the government has decided to exclude gambling and tobacco industries from the R&D Tax Incentive. It does, however, bring up some serious concerns regarding innovation’s function in solving difficult public health problems.
Going forward, we must find a balance between encouraging innovation and safeguarding public health. Innovation goes beyond just developing new products; it involves solving some of society’s most critical issues. That includes figuring out how to reduce the negative effects of gambling and tobacco while also encouraging their consumption and the economy to expand. This balancing act is crucial for the future of these industries and the public’s well-being.
The moment has come for business owners in these industries to reevaluate their R&D strategies and look for more ways to innovate. And if you’re a policymaker, it’s worth considering how we can support industries in transitioning towards more socially responsible practices.
